Theseus Pharmaceuticals, Inc. (THRX)

Exchange NASDAQ
6.02


Currency in USD (Disclaimer)
Volume:
Day's Range:

THRX Insider Trading

Transaction Date Reporting Name Relationship Shrs. Owned Type Acq./Disp. Shrs. Transacted Price(USD) Amount(USD) SEC Filing
2022-06-10 Yi Kathy director 30,000.0 A-Award A 30,000.0 5.75 172,500.00
2022-06-10 GORDON CARL L director, 10 percent owner 30,000.0 A-Award A 30,000.0 5.75 172,500.00
2022-06-10 Dukes Iain D. director, officer: Chairman 15,000.0 A-Award A 15,000.0 5.75 86,250.00
2022-06-10 Dukes Iain D. director, officer: Chairman 30,000.0 A-Award A 30,000.0 5.75 172,500.00
2022-05-17 HAYDEN DONALD J JR director 60,000.0 A-Award A 60,000.0 8.02 481,200.00
2022-02-18 Rivera Victor officer: Chief Scientific Officer 130,000.0 A-Award A 130,000.0 11.21 1,457,300.00
2022-02-18 Shakespeare William officer: President of Research and Development 180,000.0 A-Award A 180,000.0 11.21 2,017,800.00
2022-02-18 Dahms Bradford D. officer: Chief Financial Officer 150,000.0 A-Award A 150,000.0 11.21 1,681,500.00
2022-02-18 Dalgarno David officer: Chief Technical Officer 130,000.0 A-Award A 130,000.0 11.21 1,457,300.00
2022-02-18 CLACKSON TIMOTHY P director, officer: President and CEO 450,000.0 A-Award A 450,000.0 11.21 5,044,500.00
2022-02-18 Kerstein David officer: Chief Medical Officer 150,000.0 A-Award A 150,000.0 11.21 1,681,500.00
2022-01-21 GORDON CARL L director, 10 percent owner 16,542,652 P-Purchase A 111,896.0 9.97 1,115,603.12
2022-01-21 ORBIMED ADVISORS LLC director, 10 percent owner 16,542,652 P-Purchase A 111,896.0 9.97 1,115,603.12
2022-01-20 GORDON CARL L director, 10 percent owner 16,430,756 P-Purchase A 35,000.0 9.95 348,250.00
2022-01-20 ORBIMED ADVISORS LLC director, 10 percent owner 16,430,756 P-Purchase A 35,000.0 9.95 348,250.00
2022-01-19 GORDON CARL L director, 10 percent owner 16,395,756 P-Purchase A 11,521.0 9.97 114,864.37
2022-01-19 ORBIMED ADVISORS LLC director, 10 percent owner 16,395,756 P-Purchase A 11,521.0 9.97 114,864.37
2022-01-13 GORDON CARL L director, 10 percent owner 16,384,235 P-Purchase A 17,320.0 9.43 163,327.60
2022-01-13 ORBIMED ADVISORS LLC director, 10 percent owner 16,384,235 P-Purchase A 17,320.0 9.43 163,327.60
2022-01-12 GORDON CARL L director, 10 percent owner 16,366,915 P-Purchase A 18,897.0 10.06 190,103.82
2022-01-12 ORBIMED ADVISORS LLC director, 10 percent owner 16,366,915 P-Purchase A 18,897.0 10.06 190,103.82
2022-01-11 GORDON CARL L director, 10 percent owner 16,348,018 P-Purchase A 6,900.0 10.67 73,623.00
2022-01-11 GORDON CARL L director, 10 percent owner 16,341,118 P-Purchase A 1,600.0 9.81 15,696.00
2022-01-11 ORBIMED ADVISORS LLC director, 10 percent owner 16,348,018 P-Purchase A 6,900.0 10.67 73,623.00
2022-01-11 ORBIMED ADVISORS LLC director, 10 percent owner 16,341,118 P-Purchase A 1,600.0 9.81 15,696.00
2021-12-21 Dahms Bradford D. officer: Chief Financial Officer 1,970.036 P-Purchase A 1,970.036 10.15 20,000.00
2021-12-21 CLACKSON TIMOTHY P director, officer: President and CEO 348,530.0 P-Purchase A 2,600.0 9.76 25,381.46
2021-10-12 TAKEDA PHARMACEUTICAL CO LTD 10 percent owner 0.0 C-Conversion D 1,615,427.0 0.00 0.00
2021-10-12 TAKEDA PHARMACEUTICAL CO LTD 10 percent owner 1,615,427.0 C-Conversion A 1,615,427.0 0.00 0.00
2021-10-12 Shakespeare William officer: President of Research and Development 388,949.0 P-Purchase A 625.0 16.00 10,000.00
2021-10-12 ORBIMED ADVISORS LLC director, 10 percent owner 0.0 C-Conversion D 436,650.0 0.00 0.00
2021-10-12 ORBIMED ADVISORS LLC director, 10 percent owner 0.0 C-Conversion D 436,650.0 0.00 0.00
2021-10-12 ORBIMED ADVISORS LLC director, 10 percent owner 499,150.0 P-Purchase A 62,500.0 16.00 1,000,000.00
2021-10-12 ORBIMED ADVISORS LLC director, 10 percent owner 16,339,518 P-Purchase A 562,500.0 16.00 9,000,000.00
2021-10-12 ORBIMED ADVISORS LLC director, 10 percent owner 436,650.0 C-Conversion A 436,650.0 0.00 0.00
2021-10-12 ORBIMED ADVISORS LLC director, 10 percent owner 15,777,018 C-Conversion A 15,777,018 0.00 0.00
2021-10-12 Rock Springs Capital Management LP 10 percent owner 0.0 C-Conversion D 87,329.0 0.00 0.00
2021-10-12 Rock Springs Capital Management LP 10 percent owner 599,320.0 P-Purchase A 250,000.0 16.00 4,000,000.00
2021-10-12 Rock Springs Capital Management LP 10 percent owner 87,329.0 C-Conversion A 87,329.0 0.00 0.00
2021-10-12 Rock Springs Capital Management LP 10 percent owner 349,320.0 C-Conversion A 349,320.0 0.00 0.00
2021-10-12 GORDON CARL L director, 10 percent owner 0.0 C-Conversion D 436,650.0 0.00 0.00
2021-10-12 GORDON CARL L director, 10 percent owner 0.0 C-Conversion D 436,650.0 0.00 0.00
2021-10-12 GORDON CARL L director, 10 percent owner 499,150.0 P-Purchase A 62,500.0 16.00 1,000,000.00
2021-10-12 GORDON CARL L director, 10 percent owner 16,339,518 P-Purchase A 562,500.0 16.00 9,000,000.00
2021-10-12 GORDON CARL L director, 10 percent owner 436,650.0 C-Conversion A 436,650.0 0.00 0.00
2021-10-12 GORDON CARL L director, 10 percent owner 15,777,018 C-Conversion A 15,777,018 0.00 0.00
2021-10-12 Omega Fund VI, L.P. other 0.0 C-Conversion D 693,152.0 0.00 0.00
2021-10-12 Omega Fund VI, L.P. other 711,479.0 P-Purchase A 187,500.0 16.00 3,000,000.00
2021-10-12 Omega Fund VI, L.P. other 523,979.0 C-Conversion A 523,979.0 0.00 0.00
2021-10-06 Dukes Iain D. other 22,678.0 A-Award A 22,678.0 16.00 362,848.00
2021-10-06 GORDON CARL L director, 10 percent owner 22,678.0 A-Award A 22,678.0 16.00 362,848.00
2021-10-06 Yi Kathy director 22,678.0 A-Award A 22,678.0 16.00 362,848.00

Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Group doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Group or anyone involved with Discounting Cash Flows Group will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.